How can clinical trial design impact reimbursement potential?

Global Reimbursement Systems: A Market Access Perspective
June 23 from 8:30AM – 12:00PM in Boston

This tutorial is designed for pharmaceutical industry employees not familiar with market access (pricing, reimbursement, health economics) issues. Reimbursement approvals from payers (reimbursers) have become as important as regulatory approvals for pharmaceutical product success and providing access to patients. Even with reimbursement approval, payer restrictions such as step edits and individual patient approval significantly impact product usage. This tutorial will provide an overview of global reimbursement systems including health technology assessments (eg, NICE), and discuss ways in which evidence of value from clinical trials can help or limit market access.

Instructor:
John Brennick, MPA
Director, Worldwide Market Access
Janssen Global Services, LLC, United States

What’s more…Receive $100 off of your DIA 2013 Annual Meeting registration by registering for two half day tutorials or one full day tutorial. Please note purchases must be made at the same time in order to receive the discount.

Visit www.diahome.org/DIA2013 for more details on the DIA 2013 Annual Meeting being held June 23-27 in Boston, MA.

Sign up for DIA's Global SmartBrief eNews for the latest in drug development innovations worldwide.